Secretory IgA in human serum.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMID 4987529)

Published in J Immunol on July 01, 1970

Authors

R H Waldman, J P Mach, M M Stella, D S Rowe

Articles citing this

High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction. J Exp Med (1978) 1.91

The demonstration and function of antibodies in the gastrointestinal tract. Gut (1972) 1.53

Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clin Exp Immunol (1972) 1.45

Regulation of the immune response: suppressive and enhancing effects of passively administered antibody. J Exp Med (1971) 1.20

Mucosal secretory IgA and secretory piece in adult coeliac disease. Gut (1973) 1.02

Transfer of antirotaviral antibodies from mothers to their infants. J Clin Microbiol (1980) 0.99

Reassessment of levels of secretory IgA in pathological sera using a quantitative radioimmunoassay. Clin Exp Immunol (1981) 0.94

Quantitative changes associated with calving in the levels of bovine immunoglobulins in selected body fluids. I. Changes in the levels of IgA, IgGl and total protein. Can J Comp Med (1972) 0.87

Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver. Gut (1982) 0.84

Secretory component of the guinea-pig. Immunology (1975) 0.84

Determination of immunoglobulin A concentrations in human nasal secretions with a serum immunoglobulin A standard. J Clin Microbiol (1978) 0.82

Immunoglobulins and other serological parameters in Chagas' disease: evidence for increased IgA levels in the chronic digestive form. Clin Exp Immunol (1983) 0.79

Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking. Arthritis Res Ther (2016) 0.75

Articles by these authors

A research standard for human serum immunoglobulins IgG, IgA and IgM. Bull World Health Organ (1970) 7.25

Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62

Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69

Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53

Radioactive single radial diffusion: a method for increasing the sensitivity of immunochemical quantification of proteins in agar gel. Bull World Health Organ (1969) 3.31

Studies on rabbit lymphocytes in vitro. 3. Proteins, RNA, and DNA synthesis by lymphocyte cultures after stimulation with phytohaemagglutinin, with staphylococcal filtrate, with antiallotype serum, and with heterologous antiserum to rabbit whole serum. J Exp Med (1965) 3.01

Respiratory and systemic cellular and humoral immune responses to influenza virus vaccine administered parenterally or by nose drops. Cell Immunol (1972) 2.94

An international reference preparation for human serum immunoglobulins G, A and M: content of immunoglobulins by weight. Bull World Health Organ (1972) 2.82

Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization. J Exp Med (1971) 2.54

Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med (1980) 2.50

Reactive haemolysis--a distinctive form of red cell lysis. Immunology (1968) 2.32

IgD on the surface of peripheral blood lymphocytes of the human newborn. Nat New Biol (1973) 2.19

Comparison of ipecac-induced emesis with gastric lavage in the treatment of acute salicylate ingestion. J Pediatr (1969) 2.18

A research standard for human serum immunoglobulin D. Bull World Health Organ (1970) 2.09

Secretory IgA, a major immunoglobulin in most bovine external secretions. J Immunol (1971) 2.09

Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine. JAMA (1969) 2.08

A research standard for human serum immunoglobulin E. Bull World Health Organ (1970) 2.05

Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol (1999) 2.03

Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry (1972) 2.02

In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature (1974) 1.96

Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol (1968) 1.92

Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J Nucl Med (1990) 1.85

Cell-mediated immunity shown by lymphocytes from the respiratory tract. Science (1970) 1.71

An approach to the problem of noncompliance in a pediatric outpatient clinic. Am J Dis Child (1971) 1.69

Immunity to infections on secretory surfaces. J Infect Dis (1974) 1.66

Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med (1983) 1.63

Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). Lancet (1974) 1.60

In vitro combination of human and bovine free secretory component with IgA of various species. Nature (1970) 1.59

Optimal antibiotic therapy in cholera. Bull World Health Organ (1968) 1.58

Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res (1980) 1.51

Influenza infection in ferrets: role of serum antibody in protection and recovery. Infect Immun (1976) 1.48

Influenza virus neutralizing antibody in human respiratory secretions. J Immunol (1968) 1.48

Metabolism of human immunoglobulin D (IgD). J Clin Invest (1966) 1.46

Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line. EMBO J (1982) 1.46

Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clin Exp Immunol (1972) 1.45

Immunosuppression during influenza virus infection. Infect Immun (1974) 1.45

Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol (1970) 1.43

Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages. Clin Exp Immunol (1975) 1.42

IgA with "secretory piece" in bovine colostrum and saliva. Nature (1969) 1.42

An evaluation of influenza immunization: influence of route of administration and vaccine strain. Bull World Health Organ (1969) 1.40

Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues. Immunochemistry (1973) 1.40

Probable gallbladder infection in convalescent cholera patients. Lancet (1967) 1.39

Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines. Proc Natl Acad Sci U S A (1980) 1.39

Preventive health care in the HMO: cost benefit issues. J Am Coll Health Assoc (1978) 1.39

Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med (1970) 1.39

Balkanization of medical specialties. J Gen Intern Med (1991) 1.38

Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. II. Selective destruction of different Leishmania species in activated guinea-pig and mouse macrophages. Clin Exp Immunol (1975) 1.35

Immunoglobulin D in serum, body fluids and lymphoid tissues. Clin Exp Immunol (1968) 1.34

Immune response of the human respiratory tract. I. Immunoglobulin levels and influenza virus vaccine antibody response. J Immunol (1973) 1.30

Use of utilization review to assess the quality of pediatric inpatient care. Pediatrics (1972) 1.30

Isolation and characterization of carcinoembryonic antigen (CEA) extracted from normal human colon mucosa. Immunochemistry (1977) 1.30

Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol (1976) 1.29

Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens. Clin Exp Immunol (1977) 1.27

Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) (1982) 1.25

Antibody-induced movement of membrane components of Leishmania enriettii. J Exp Med (1974) 1.23

Light chain types in plasma cells that produce IgD. Immunology (1969) 1.23

Plasma immunoglobulin concentrations in mothers and newborn children with special reference to placental malaria: Studies in the Gambia, Nigeria, and Switzerland. Bull World Health Organ (1973) 1.23

Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res (1994) 1.23

Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res (1987) 1.22

Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB-ALL. Eur J Immunol (1986) 1.22

Intravaginal immunization of humans with Candida albicans. J Immunol (1972) 1.22

Assessing research productivity: evaluating journal publication across academic departments. Acad Med (1989) 1.21

Studies on human IgD. II. The lack of skin sensitizing and complement fixing activities of immunoglobulin D. Immunochemistry (1969) 1.20

Protective studies with a group A streptococcal M protein vaccine. II. Challange of volenteers after local immunization in the upper respiratory tract. J Infect Dis (1975) 1.20

Immunoglobulin E: a new class of human immunoglobulin. Immunology (1968) 1.19

Antibodies of IgA and IgG class in normal human urine. Immunology (1967) 1.19

The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus. JAMA (1970) 1.18

Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers. J Clin Invest (1973) 1.17

Immune haemolysis in agar: demonstration of the protective action of antibodies. Immunology (1967) 1.17

Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guérin. J Infect Dis (1977) 1.17

Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A Streptococcus. J Infect Dis (1978) 1.16

Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res (1983) 1.16

Specificity of respiratory secretion antibody against influenza virus. J Immunol (1970) 1.15

Cholera immunology. II. Serum and intestinal secretion antibody response after naturally occurring cholera. J Infect Dis (1972) 1.13

The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells. J Immunol (1985) 1.13

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest (1986) 1.13

Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine. N Engl J Med (1970) 1.13

Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability. Int J Cancer (1993) 1.10

Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines. J Immunol (1983) 1.10

Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses. J Infect Dis (1973) 1.10

Gastroenteritis: etiology, pathophysiology and clinical manifestations. Medicine (Baltimore) (1979) 1.09

IgE levels in external secretions. Int Arch Allergy Appl Immunol (1973) 1.09

Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. Int J Cancer (1984) 1.09

Influenza immunization: field trial on a university campus. J Infect Dis (1972) 1.07

Concentration of serum-immunoglobulins in healthy young adult males estimated by assay against the international reference preparation. Lancet (1972) 1.07

Established murine cytolytic T-cell lines as tools for a somatic cell genetic analysis of T-cell functions. Immunol Rev (1980) 1.07

Plasma immunoglobulin concentrations in twins. Clin Exp Immunol (1968) 1.07

Effect of isoprinosine against challenge with A(H3N2)-Hong Kong influenza virus in volunteers. Antimicrob Agents Chemother (1973) 1.07

Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice. Cancer (1991) 1.07

Antigenic sites in carcinoembryonic antigen. Cancer Res (1989) 1.06

A naturally occurring fragment related to the heavy chains of immunoglobulin G in normal human urine. Nature (1966) 1.06

Identification of secretory IgA, free secretory piece and serum IgA in the ovine and caprine species. Immunochemistry (1970) 1.06

Rhesus leukocyte-associated herpesvirus. I. Isolation and characterization of a new herpesvirus recovered from rhesus monkey leukocytes. J Infect Dis (1973) 1.04

Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model. Int J Cancer (1988) 1.03

Immunologic mechanisms in hypersensitivity pneumonitis. I. Evidence for cell-mediated immunity and complement fixation in pigeon breeders' disease. J Allergy Clin Immunol (1973) 1.03

Rubella immunization of volunteers via the respiratory tract. Infect Immun (1973) 1.02

Antibody-induced movement of protozoan surface membrane antigens. Ann N Y Acad Sci (1975) 1.02